(Source: Heally, June 2026) Semaglutide Prescription Shift: Obesity Up 8%, Diabetes Down 6.4% Between March 2025 and June 2025, semaglutide prescriptions for treating diabetes decreased by 6.4% while prescriptions for obesity treatment increased by 8% in the same period
de Jong SC, Stehouwer CD, van den Berg M, Kostense PJ, Alders D, Jakobs C, Pals G, and Rauwerda JA (1999b)
Retatrutide is still in the clinical pipeline
What AI Reveals What are the reasons why a UK GP surgery refuses to give a b12 injection a day earlier than it is due to a patient with Pernicious Anaemia
Grey market sources should be avoided entirely due to quality and safety concerns